Cole Hugh M

Chief Operating Officer at Jounce Therapeutics, Inc.; SVP, Chief Business Officer at ARIAD PHARMACEUTICALS INC

Sold, on record
$425k
Dollars the filings state
Form 4 sales
8
Latest Jan 10, 2023
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale ARIAD PHARMACEUTICALS INCPlan not stated
    Jun 28, 2016 2016

    Sold 6,012 shares at $7.05 ($42k)

    Cole Hugh M, SVP, Chief Business Officer

    Sold 16.7% of holdings ($253k position)29,916 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale Jounce Therapeutics, Inc.Plan not stated
    Aug 16, 2019 +1144 days

    Sold 2,336 shares at $3.99 ($9k)

    Cole Hugh M, Chief Business Officer

    Sold 6.1% of holdings ($154k position)36,214 shares leftFirst sale on recordFiling

  3. 3 Form 4 sale Jounce Therapeutics, Inc.Plan not stated
    Jan 7, 2020 +144 days

    Sold 2,624 shares at $7.78 ($20k)

    Cole Hugh M, Chief Business Officer

    Sold 7.2% of holdings ($282k position)33,590 shares leftFiling

  4. 4 Form 4 sale Jounce Therapeutics, Inc.Plan not stated
    Aug 18, 2020 +224 days

    Sold 2,182 shares at $4.71 ($10k)

    Cole Hugh M, Chief Business Officer

    Sold 3.4% of holdings ($299k position)61,408 shares leftFiling

  5. 5 Form 4 sale Jounce Therapeutics, Inc.Plan not stated
    Jan 8, 2021 +143 days

    Sold 6,219 shares at $6.89 ($43k)

    Cole Hugh M, Chief Business Officer

    Sold 10.1% of holdings ($423k position)55,189 shares left2.7x usual sizeFiling

  6. 6 Form 4 sale Jounce Therapeutics, Inc.Unusual
    Jan 22, 2021 +14 days

    Sold 18,000 shares at $11.95 ($215k)

    Cole Hugh M, Chief Business Officer

    Sold 27.6% of holdings ($779k position)47,189 shares left7.3x usual sizeFiling

  7. 7 Form 4 sale Jounce Therapeutics, Inc.Plan not stated
    Jan 10, 2022 +353 days

    Sold 9,673 shares at $6.88 ($67k)

    Cole Hugh M, Chief Business Officer

    Sold 13.1% of holdings ($509k position)64,216 shares left1.6x usual sizeFiling

  8. 8 Form 4 sale Jounce Therapeutics, Inc.Plan not stated
    Jan 10, 2023 +365 days

    Sold 16,634 shares at $1.11 ($18k)

    Cole Hugh M, Chief Operating Officer

    Sold 13.1% of holdings ($141k position)110,082 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (8)

Form 144 notices and Form 4 sales by Cole Hugh M
Source
Jan 10, 2023Jan 11, 2023Jounce Therapeutics, Inc.Chief Operating OfficerForm 4 sale16,634$18k13.1%Plan not statedSEC
Jan 10, 2022Jan 11, 2022Jounce Therapeutics, Inc.Chief Business OfficerForm 4 sale9,673$67k13.1%Plan not statedSEC
Jan 22, 2021Jan 25, 2021Jounce Therapeutics, Inc.Chief Business OfficerForm 4 sale18,000$215k27.6%UnusualSEC
Jan 8, 2021Jan 11, 2021Jounce Therapeutics, Inc.Chief Business OfficerForm 4 sale6,219$43k10.1%Plan not statedSEC
Aug 18, 2020Aug 18, 2020Jounce Therapeutics, Inc.Chief Business OfficerForm 4 sale2,182$10k3.4%Plan not statedSEC
Jan 7, 2020Jan 10, 2020Jounce Therapeutics, Inc.Chief Business OfficerForm 4 sale2,624$20k7.2%Plan not statedSEC
Aug 16, 2019Aug 16, 2019Jounce Therapeutics, Inc.Chief Business OfficerForm 4 sale2,336$9k6.1%Plan not statedSEC
Jun 28, 2016Jun 29, 2016ARIAD PHARMACEUTICALS INCSVP, Chief Business OfficerForm 4 sale6,012$42k16.7%Plan not statedSEC